110,000 Shares in DENTSPLY SIRONA Inc. $XRAY Purchased by Truepoint Inc.

Truepoint Inc. bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 110,000 shares of the medical instruments supplier’s stock, valued at approximately $1,396,000. Truepoint Inc. owned 0.06% of DENTSPLY SIRONA as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. Mitsubishi UFJ Trust & Banking Corp grew its stake in DENTSPLY SIRONA by 1,836.7% during the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 105,938 shares of the medical instruments supplier’s stock worth $1,344,000 after buying an additional 100,468 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of DENTSPLY SIRONA by 8.2% during the second quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock valued at $5,598,000 after acquiring an additional 26,610 shares during the period. Commonwealth Equity Services LLC grew its position in shares of DENTSPLY SIRONA by 38.4% during the third quarter. Commonwealth Equity Services LLC now owns 804,934 shares of the medical instruments supplier’s stock worth $10,215,000 after acquiring an additional 223,339 shares during the last quarter. CWM LLC increased its holdings in shares of DENTSPLY SIRONA by 84.3% in the 3rd quarter. CWM LLC now owns 420,470 shares of the medical instruments supplier’s stock worth $5,336,000 after acquiring an additional 192,373 shares during the period. Finally, Allianz Asset Management GmbH lifted its position in DENTSPLY SIRONA by 63.6% in the 3rd quarter. Allianz Asset Management GmbH now owns 1,355,643 shares of the medical instruments supplier’s stock valued at $17,203,000 after purchasing an additional 526,973 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Gregory T. Lucier sold 82,200 shares of DENTSPLY SIRONA stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $11.14, for a total value of $915,708.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several recent analyst reports. Mizuho upped their target price on shares of DENTSPLY SIRONA from $14.00 to $16.00 and gave the stock a “neutral” rating in a research report on Monday. Barclays started coverage on DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price objective for the company. Stifel Nicolaus set a $13.00 target price on DENTSPLY SIRONA in a research note on Thursday, November 6th. Weiss Ratings reiterated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, January 21st. Finally, Wells Fargo & Company raised their price target on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $14.42.

DENTSPLY SIRONA Trading Down 0.8%

Shares of XRAY stock opened at $13.33 on Friday. The stock has a 50-day simple moving average of $12.61 and a 200 day simple moving average of $12.48. The stock has a market capitalization of $2.66 billion, a P/E ratio of -4.44, a P/E/G ratio of 1.57 and a beta of 0.97. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $17.18. The company has a quick ratio of 1.03, a current ratio of 1.51 and a debt-to-equity ratio of 1.50.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.01). DENTSPLY SIRONA had a negative net margin of 16.25% and a positive return on equity of 18.85%. The business had revenue of $961.00 million during the quarter, compared to analyst estimates of $926.40 million. During the same period in the previous year, the company posted $0.26 earnings per share. DENTSPLY SIRONA’s revenue was up 6.2% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were paid a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 4.8%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -21.33%.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.